UBS Group’s Apogee Therapeutics APGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.65M | Sell |
107,157
-594,752
| -85% | -$25.8M | ﹤0.01% | 3129 |
|
|
2025
Q1 | $26.2M | Buy |
701,909
+160,623
| +30% | +$6M | ﹤0.01% | 1612 |
|
|
2024
Q4 | $24.5M | Buy |
541,286
+489,466
| +945% | +$22.2M | ﹤0.01% | 1609 |
|
|
2024
Q3 | $3.04M | Buy |
51,820
+1,330
| +3% | +$78.1K | ﹤0.01% | 2682 |
|
|
2024
Q2 | $1.99M | Sell |
50,490
-25,541
| -34% | -$1.01M | ﹤0.01% | 2854 |
|
|
2024
Q1 | $5.05M | Buy |
+76,031
| New | +$5.05M | ﹤0.01% | 2180 |
|
|
2023
Q4 | – | Sell |
-3,557
| Closed | -$75.8K | – | 8047 |
|
|
2023
Q3 | $75.8K | Buy |
+3,557
| New | +$75.8K | ﹤0.01% | 4905 |
|